BBLG Approaching Crucial Stage

BBLG READ THE FULL BBLG RESEARCH REPORT Bone Biologics (NASDAQ:BBLG) is a clinical-stage biotechnology company focused on transforming the multibillion-dollar spine fusion and bone regeneration market ...
Benzinga.com

Why Is Bone Biologics Stock Surging On Friday?

Bone Biologics Corporation (NASDAQ:BBLG) stock is trading higher on Friday, with a session volume of 17.22 million compared to the average volume of 38.795K as per data from Benzinga Pro. The company ...
Nasdaq

BONE BIOLOGICS Earnings Results: $BBLG Reports Quarterly Earnings

BONE BIOLOGICS ($BBLG) posted quarterly earnings results on Monday, May 12th. The company reported earnings of -$0.32 per share, beating estimates of -$0.49 by $0.17 ...
Nasdaq

Bone Biologics To Implement 1-for-6 Reverse Stock Split Effective June 10, 2025

(RTTNews) - Bone Biologics Corporation (BBLG) has announced a 1-for-6 reverse stock split of its common stock, which will take effect at 12:01 a.m. ET on Tuesday, June 10, 2025. The company's shares ...
Seeking Alpha

Bone Biologics Announces 1-for-6 Reverse Stock Split

Bone Biologics Corporation (BBLG) (“Bone Biologics” or the “Company”) (Nasdaq: BBLG, BBLGW), a developer of orthobiologic products for spine fusion markets, today announced a planned reverse stock ...